This inventor holds 3 USPTO granted patents and 12 published patent applications and 1 EPO patent. Top assignees: Breakthrough Pharmaceuticals Inc., Chinese Academy of Sciences, Zhejiang Yangli Pharmaceutical Technology Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 3,364 
1 out of 3 Years Active: 2025-2026
Title: Na Gao - Innovator in Pharmaceutical Chemistry
Introduction
Na Gao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds.
Latest Patents
Na Gao holds a patent for an indazole-fused cyclic compound. This patent describes a preparation method for a novel indazole compound and its use in the development of drugs aimed at treating related diseases. Specifically, the patent discloses a compound of formula (II) and a pharmaceutically acceptable salt thereof. This innovation has the potential to impact the pharmaceutical industry significantly.
Career Highlights
Na Gao is associated with Zhejiang Yangli Pharmaceutical Technology Co., Ltd., where he applies his expertise in drug development. His work focuses on creating effective pharmaceutical solutions that address various health issues.
Collaborations
Na Gao collaborates with notable colleagues, including Ke An and Guoping Hu, who contribute to his research endeavors. Their combined efforts enhance the innovative capacity of their projects.
Conclusion
Na Gao's contributions to pharmaceutical chemistry through his patent and collaborative work highlight his role as an influential inventor in the industry. His innovative approaches continue to pave the way for advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile